Sign in
4

Changes in Ownership

XTL BIOPHARMACEUTICALS LTD Filed Acc 0001144204-06-036007

CEO bought 1,600 shares at $2.98 ($4,768)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BENTSUR RON CEO 2006-08-25 Purchase +1,600 $2.98 $4,768 4,822 D
Open-market purchases · 1,600 sh · avg $2.98 · $4,768
Loading xslF345X02/v051516_ex.xml…